Related by context. All words. (Click for frequent words.) 75 TTR gene 71 mesothelin 70 HER-2/neu 70 EGFRvIII 70 HER2 receptor 70 HER2/neu 70 EpCAM 69 somatostatin receptors 69 hCG beta 69 MUC1 69 MAGE A3 69 ErbB 69 WT1 69 tumor antigen 69 carcinoembryonic antigen 69 A3 adenosine receptor 68 NY ESO 68 epithelial tumors 68 chemokine receptor 68 pDCs 68 ErbB2 68 CD# molecule 68 FLT3 68 carcinoembryonic antigen CEA 68 VEGF receptor 68 T#I [002] 67 BRAF mutation 67 TNF α 67 CCR9 67 uPAR 67 EGFR protein 67 AAV2 67 EGFr 67 alpha folate receptor 67 survivin 67 vimentin 67 androgen receptor AR 67 ERBB2 67 metastatic melanomas 67 IGF 1R 67 tumor specific antigen 66 CD# antigen 66 CCR2 66 mutated BRAF gene 66 EGF receptor 66 SPINK1 66 Enzastaurin 66 Mesothelin 66 HER2 protein 66 receptor CXCR4 66 TNFa 66 AGTR1 66 EphA2 66 eIF 4E 65 K ras mutations 65 specific lectin receptors 65 surface glycoprotein 65 TNFalpha 65 MLL AF9 65 IGFBP 3 65 CanAg 65 mutated KRAS 65 TRAIL R2 65 folate receptor 65 miR #b [001] 65 sphingosine 1 65 EphB4 65 CCX# 65 cytokeratin 65 huC# DM4 65 FGFR1 65 HepG2 cells 65 c MYC 65 Immunohistochemical analysis 65 EGFR inhibitors 65 iNOS 65 extracellular domain 65 phosphate S1P 64 C5aR 64 ENMD # 64 isotype 64 serotonin receptor 64 CXCR4 64 LHRH receptor 64 PDGFR 64 hCG Beta 64 neutralizing antibody 64 protein tyrosine phosphatase 1B 64 IGF1R 64 HER2 expression 64 humanized monoclonal antibody 64 vWF 64 immunostimulatory 64 NS4A 64 PTPN# 64 T#I mutation 64 TNFα 64 IFN gamma 64 SGLT2 64 PC3 cells 64 TAp# 64 pathophysiological effects 64 cyclin E 64 mRNA transcripts 64 glioma cells 64 ADPKD 64 CD# receptor 64 HDAC6 64 HER2 receptors 64 M2 subunit 64 c MET 64 AT1R 64 cathepsins 64 hTERT 64 epithelial cells lining 63 protein kinase inhibitor 63 Gleevec resistant 63 Lyn kinase 63 basophils 63 activated lymphocytes 63 IGFBP2 63 HGS ETR2 63 #HT#A 63 ZNF# 63 lysophosphatidic acid LPA 63 E#F# 63 LHRH receptors 63 VEGFR1 63 IgG1 63 LRP6 63 EGFR mutations 63 IgG1 antibody 63 ENaC 63 humanized antibody 63 PI3 kinase 63 HuLuc# 63 selective modulator 63 cytotoxin 63 IL 1β 63 seliciclib 63 V#F 63 Epidermal Growth Factor Receptor 63 adhesion molecule 63 EGFR pathway 63 IL 1ß 63 IL #R 63 TNFR1 63 P selectin 63 hCG β 63 MGd 63 Survivin 63 viral antigens 63 IFN γ 63 interferon γ 63 HAAH 63 oncoprotein 63 Clusterin 63 cytolytic 63 ADAM# 63 CD#L 63 chemokine 63 TIMP 1 63 colorectal carcinoma 63 estrogen receptor ER 63 AEG# 63 potent inhibition 63 GBM tumors 63 XmAb# 63 TGF β 63 TLE3 63 neuroblastoma tumors 63 KRAS oncogene 63 inhibitory receptor 63 Ki# 63 caveolin 1 63 TGF alpha 63 glucocorticoid receptors 63 NKG2D 63 HGS ETR1 63 Cathepsin B 63 IL 1beta 63 monocyte chemoattractant protein 63 constitutively 63 HER2 neu 62 Her2 62 mammaglobin 62 miR #a [002] 62 5 HT4 receptor 62 milatuzumab 62 MMP9 62 CTLA 4 62 LHRH 62 Bcr Abl 62 activin 62 glioblastoma cells 62 CXCL5 62 Protein Kinase C 62 Aurora kinase 62 nucleolin 62 Trp p8 62 CDK4 62 uPA 62 decitabine 62 Her2/neu 62 adenocarcinomas 62 muscarinic 62 GPR# [002] 62 serous ovarian cancer 62 HER2 overexpression 62 superantigens 62 CCN2 62 IgG antibodies 62 CXCR2 62 BRAF V#E mutation 62 HEK# cells 62 interferon IFN 62 ERK1 2 62 cell adhesion molecule 62 generation antisense inhibitor 62 eotaxin 62 rhIL 7 62 B7 H4 62 VEGFR2 62 TCF#L# 62 fusion protein 62 adecatumumab 62 inducible nitric oxide synthase 62 CR# vcMMAE 62 macrophage colony stimulating 62 GRN# 62 BCR ABL 62 BRAF mutations 62 IGFBP7 62 cyclin D1 62 replicon 62 receptors EGFR 62 ERalpha 62 CCR1 62 Kinoid 62 peptide antigens 62 adenoviral 62 BMP2 62 miRNA genes 62 HCV protease 62 N cadherin 62 IGF IR 62 castrate resistant 62 FGFR2 62 CTLs 62 RANKL 62 autoantibody 62 KIT mutations 62 endogenous ligands 62 granzyme B 62 PSMA ADC 62 synovial tissue 62 ABCB1 62 5alpha reductase 62 activating mutations 62 myeloma cells 62 oxysterols 62 ADAMTS# 62 acid phosphatase PAP 62 aT cell 62 RAV# 61 histone deacetylases 61 Epidermal growth 61 CXCR4 receptor 61 alkylating agent 61 FasL 61 KRAS mutations 61 PKCi 61 Foxp3 61 Symadex 61 CD# [002] 61 co stimulatory molecules 61 Tyrima 61 BCR ABL protein 61 epithelial cancers 61 LRP5 61 FGFR 61 PPARg 61 PARP inhibition 61 S#A# [002] 61 glutamic acid decarboxylase 61 CCL# 61 Factor VEGF 61 downregulated 61 proteolytic cleavage 61 HDACi 61 MDR1 61 cMET 61 TOP2A 61 GSTP1 61 luteinizing hormone releasing 61 receptor CD# 61 mRNA expression 61 syngeneic 61 immunogen 61 PI3K inhibitor 61 aberrantly activated 61 hENT1 61 liver metastases 61 cytoprotective 61 SOD1 gene 61 c myc 61 E cadherin expression 61 histone deacetylase HDAC 61 ApoB 61 interleukin IL -# 61 PARP inhibitor 61 orally administered inhibitor 61 VIPR2 61 gastric adenocarcinoma 61 GPR# [001] 61 TRAIL receptor 61 virulence genes 61 miR #a [001] 61 receptor blocker 61 castration resistant prostate cancer 61 HER2/neu protein 61 EZH2 61 inhibit EGFR 61 epitope 61 peripheral blood mononuclear 61 specific membrane antigen 61 serotonin 2C receptor 61 CD#b 61 antitumor effects 61 proteasome inhibitor 61 CENP E 61 PC# cells 61 KIF6 gene 61 immune modulating 61 EGFR HER2 61 MIF protein 61 stromal derived 61 AhR 61 kinase inhibition 61 chemokine receptors 61 FUS1 61 thrombopoietin 61 SGLT 61 sodium glucose cotransporter 61 TG# [003] 61 alvespimycin 61 HER2 positive metastatic breast 61 EGFR tyrosine kinase inhibitors 61 p# Shc 61 Galectins 61 TrkA 61 miR #b [002] 61 somatostatin 61 CDKN2A 61 clusterin 61 factor HGF 61 claudin 61 calcineurin 61 NSCLC tumors 61 dopamine D1 61 mTOR mammalian target 61 GNAQ 61 cytochrome P 61 VEGFR 61 enkephalin 61 #T# tumor 61 CCR7 61 Bezielle 61 Xanafide 61 tyrosine kinase inhibitor 61 monocytes macrophages 61 cytokine interleukin 61 galectins 61 MGMT gene 61 neuroblastoma cells 61 colorectal carcinomas 61 receptor tyrosine kinase inhibitor 61 TGF ß 61 chimeric monoclonal antibody 61 mapatumumab 61 c Src 61 MAGE A3 protein 61 AKT1 61 receptor tyrosine kinase 61 MAPK pathway 61 related apoptosis inducing 61 bronchial epithelial cells 61 antibody MAb 61 prostate cancer antigen prostatic 61 CXCR7 61 antiangiogenic 61 endostatin 61 HIF 1alpha 61 NF kB pathway 61 tNOX 61 Sudhir Agrawal D.Phil 61 CD# monoclonal antibody 61 preclinically 61 MAGE A3 ASCI 61 tumor antigens 61 B7 H3 61 neutralizing antibody responses 61 anthracycline chemotherapy 61 Tumor Necrosis Factor 61 missense mutations 61 receptor alpha 61 intratumoral injection 61 IFN α 61 CLL cells 60 antisense inhibitors 60 IMC A# 60 effector function 60 targeting CD# 60 TGF beta1 60 PTP 1B 60 SIRT2 60 EGFP 60 thioredoxin 60 TGFBR1 * 6A 60 transfected 60 Proxinium TM 60 EGF receptors 60 integrin receptors 60 metaglidasen 60 epithelial markers 60 HLA DR 60 progesterone receptor 60 serine protease 60 S. maltophilia 60 NQO1 60 hypermethylation 60 TRAIL induced apoptosis 60 antigen CD# 60 hormone gastrin 60 antibody titers 60 brostallicin 60 transmembrane protein 60 CIMZIA TM 60 III EGFRvIII 60 Tarvacin 60 MUC1 protein 60 MetAP2 60 flavopiridol 60 tryptase 60 locoregional recurrence 60 HER3 60 antiproliferative effects 60 cyclooxygenase 60 estrogen receptor 60 Wwox 60 GM CSF 60 Treg cell 60 p# activation 60 GI mucosa resulting 60 HLA B# 60 RANK ligand 60 CA4P 60 leukemic cell 60 complete cytogenetic response 60 XL# inhibits 60 plasminogen 60 pegylated liposomal doxorubicin 60 hepatoma 60 HOTAIR 60 microRNA miR 60 Fibroblast Growth Factor Receptor 60 JAK3 60 breast carcinomas 60 nab paclitaxel 60 PHD2 60 ALB # 60 mutant p# 60 plasma kallikrein 60 S. pyogenes 60 cytokine signaling 60 MMP2 60 CD# expression [001] 60 imatinib Gleevec 60 DLL4 60 pan HDAC inhibitor 60 factor receptor EGFR 60 lymphoid cells 60 estrogen receptor progesterone receptor 60 DFMO 60 Eg5 60 Bavituximab 60 CD# + [002] 60 Stat5 60 CagA 60 microglial activation 60 glioblastoma tumors 60 H#K#me# 60 CEACAM1 60 promoter methylation 60 IgM 60 PBMCs 60 HCV replicon 60 bcl 2 60 interferon gamma 60 BRAF V#E 60 TLR9 60 ovarian carcinoma 60 pDC 60 androgen independent 60 Janus kinase 60 catenin 60 apoptotic pathway 60 ErbB3 60 trastuzumab Herceptin ® 60 CIMZIA ™ 60 Notch receptor 60 tumor suppressor protein 60 B Raf 60 castration resistant 60 leukemia AML 60 CTGF 60 MAb 60 antisense oligonucleotides 60 cyclin dependent kinase 60 lymphangiogenesis 60 Angiolix 60 gemcitabine carboplatin 60 CDK inhibitor 60 HBx 60 xenograft models 60 selective antagonists 60 N Myc 60 nucleoside analogues 60 Zolinza 60 Cytotoxic T 60 HGPIN 60 delta isoform 60 IGFBP 60 RAR beta 60 selective agonist 60 selectively inhibited 60 arginase 60 downregulation 60 TIMP 60 B lymphocyte stimulator 60 CD#c 60 mutant SOD1 60 RANTES 60 elotuzumab 60 hedgehog pathway 60 ChR2 60 EphB2 60 RhoA 60 IMA# 60 PDGF B 60 hypermethylated 60 suppressor cells 60 orthotopic model 60 PlGF 60 CD# + [001] 60 BRCA deficient 60 alkaline phosphatase 60 proinflammatory cytokine 60 binding affinity 60 CD# protein 60 retinoic acid receptor 60 HLA molecules 60 imatinib therapy 60 chlorambucil 60 circulating EPCs 60 Wnt#b 60 lymph node metastases 60 JAK2 60 tyrosine kinase receptor 60 effector functions 60 cytostatic 60 splenectomized patients 60 KRAS wild 60 neoplastic cells 60 protein kinase C 60 angiogenic 60 colon carcinoma 60 taxane chemotherapy 60 NOD SCID mice 60 HPV# 60 Fas ligand 60 gene amplification 60 transfected cells 60 PTHrP 60 tumorigenicity 60 eNOS 60 factor Xa 60 p# MAPK 60 Imprime PGG 60 IMPDH 60 cAMP signaling 60 binds selectively 60 NKX#.# 60 P#X# receptor 59 compound AEZS 59 plasma kallikrein inhibitor 59 caveolin 59 antitumor 59 pro apoptotic 59 nestin 59 invasive ductal 59 NS#/#A protease 59 myeloid cells 59 GM CSF granulocyte 59 cytotoxic agents 59 B7 H1 59 mTOR inhibitors 59 Factor Receptor 59 mesotheliomas 59 multi kinase inhibitor 59 protein tyrosine kinase 59 lymphoid tissues 59 transgene expression 59 Traficet EN 59 E selectin 59 Î ² 59 PCa 59 pro angiogenic 59 GSK3B 59 HDAC enzymes 59 vascular endothelial cells 59 Seliciclib 59 humanized monoclonal antibodies 59 PI3K Akt 59 NS3 59 Ep CAM 59 OMP #M# 59 eIF4E 59 metastatic colorectal 59 P#X# 59 HQK 59 mitogen activated protein kinase 59 serum antibodies 59 Epstein Barr virus EBV 59 isoform 59 short hairpin RNAs 59 Tarvacin Anti Viral 59 chemically modified siRNA 59 intercellular adhesion molecule 59 IL#B 59 trans retinoic acid 59 FGF2 59 KLF# 59 Olaparib 59 annexin V 59 Abeta# 59 PAK1 59 pertuzumab 59 Ocrelizumab 59 immunoglobulin G 59 progesterone receptors 59 antiangiogenic therapy 59 Nod1 59 IL #p# 59 induces apoptosis 59 cell lymphoma CTCL 59 myelofibrosis polycythemia vera 59 EGFR mutation 59 p# mitogen activated 59 Omacetaxine 59 EGFR mutant 59 plasmacytoid dendritic cells 59 leukemic cells 59 receptor subtype 59 IgG antibody 59 tumor vasculature 59 TRAIL receptors 59 oral prodrug 59 PPARγ 59 HIF 1a 59 LymphoStat B belimumab 59 L1 CAM 59 S/GSK# 59 selective inhibition 59 RRM1 59 mda 7 59 untreated metastatic melanoma 59 Wnt signaling pathway 59 CD1d 59 immunohistochemical staining 59 glycogen synthase kinase 59 engineered RAP peptides 59 matrix metalloproteinase 59 JAK inhibitors 59 oblimersen 59 K#R [002] 59 4CMenB 59 HER2 59 SCCHN 59 cytotoxic T 59 ERCC1 59 paclitaxel cisplatin 59 EGFR HER 59 Notch receptors 59 variant allele 59 GPC3 59 PI3K 59 mGluR2 59 CXCL# 59 pancreatic carcinoma 59 multidrug resistance 59 MDM2 59 MET amplification 59 heterologous 59 GRN#L 59 soluble receptor 59 glucagon receptor 59 FGFR3 59 azacytidine 59 immunomodulation 59 selective kinase inhibitor 59 neovasculature 59 proteoglycan 59 LPA1 59 GATA3 59 CYT# potent vascular disrupting 59 HBeAg positive patients 59 bleomycin 59 PDGF receptor 59 dsRNA 59 non mutated KRAS 59 topoisomerase 59 glycosylated 59 Aflibercept 59 mRCC 59 CYP# [002] 59 neutralizing antibodies 59 drug metabolizing enzymes 59 5 lipoxygenase 59 gp# [002] 59 estrogen receptor alpha 59 anti EGFR antibody 59 C EBP alpha 59 vascular disrupting agents 59 susceptibility gene 59 antagomirs 59 antiapoptotic 59 E. faecalis 59 PTP1B 59 p# mutation 59 Notch1 59 CpG 59 histological subtype 59 HSP# inhibitor 59 mutated KRAS gene 59 HBsAg 59 BRAF protein 59 Smoothened 59 hypoxia inducible factor 59 protein interleukin 59 neuropilin 59 Leydig cells 59 NFkappaB 59 CD# antibody [001] 59 #ME# 59 splice variants 59 enzastaurin 59 renal cell carcinomas 59 CD8 + 59 p#INK#a 59 dimerization 59 TGF ß1 59 KLF4 59 humanised monoclonal antibody 59 melatonin receptor 59 PPARgamma 59 hormone LHRH 59 VE cadherin 59 FGFR4 59 renal fibrosis 59 glioblastoma multiforme GBM 59 mTOR pathway 59 chitinase 59 deacetylation 59 adrenoceptor 59 gastrin 59 angiogenesis inhibitor 59 immunotoxin 59 HBeAg negative 59 TGF beta pathway 59 Sphingomab 59 cytokines IL 59 alpha2 59 CD# CD# 59 SOD1 59 procaspase 3 59 SCIg 59 constitutively active 59 phosphorylated 59 HER2 HER2 59 EGFR gene 59 Akt activation 59 nicotinic acetylcholine receptor 59 potent antiproliferative 59 NKT cells 59 transmembrane receptor 59 Th2 59 Hypoxia Inducible Factor 59 hA# 59 ELACYT 59 depsipeptide 59 ALDH 59 thromboxane A2 59 Akt1 59 plasma pharmacokinetics 59 5 HT6 receptor 59 NFkB 59 PKM2 59 immunoconjugate 59 bispecific antibody 59 bactericidal activity 59 antitumor activity 59 pomalidomide 59 hematopoietic cells 59 Macrophage 59 JAK2 enzyme 59 homodimers 59 FGFs 59 clade B 59 pancreatic islet 59 alpha synuclein gene 59 lutetium plus 59 HER2 positive cancers 59 PKC# 59 HER1 59 TRAIL Receptor 59 skeletal metastases 59 cyclin dependent kinases 59 serine proteases 59 CD8 T cell 59 beta interferons 59 matrix metalloproteinases 59 idarubicin 59 TMPRSS2 ERG 59 SNP rs# [002] 59 RAS pathway 59 PI3K inhibitors 59 TERT 59 investigational humanized monoclonal antibody 59 cyclic AMP cAMP 59 PEG SN# 59 inverse agonist 59 dephosphorylation 59 MT#/MEDI-# 58 siRNA therapeutic 58 kDa protein 58 IL# [001] 58 cyclin dependent kinases CDKs 58 heparanase 58 cancer immunotherapeutics 58 oncoproteins 58 COX2 58 Her-2/neu 58 Th2 cells 58 beta1 integrin 58 DGAT1 58 IgA antibodies 58 somatic mutations 58 TLR8 58 dexpramipexole 58 KIAA# 58 Rap1 58 lung metastases 58 cytochrome P# 58 CD8 T cells 58 estrogen receptor beta 58 vidofludimus 58 E7 proteins 58 EGFR 58 glucocorticoid receptor 58 metastatic neuroendocrine tumors 58 p#HER# 58 TACI Ig 58 leukaemias 58 recurrent glioblastoma multiforme 58 NFκB 58 tumor necrosis 58 hormone receptor negative 58 PCA3 gene 58 GRK2 58 thymidylate synthase TS 58 VSV G 58 proto oncogene 58 Bortezomib 58 lymphoid 58 factor receptor FGFR 58 Irinotecan 58 INCB# [001] 58 Hsp# inhibitor 58 MLH1 58 β amyloid 58 lymphocytosis 58 LHRH receptor positive 58 shRNAs 58 amyloid ß 58 Flt3 58 MEK ERK 58 cathepsin B 58 ERK pathway 58 rhabdoid tumors 58 OXi# 58 thyroglobulin 58 tumor xenografts 58 prospectively defined 58 Dasatinib 58 proinflammatory cytokines 58 EndoTAGTM 1 58 immunoreactivity 58 induce apoptosis 58 radiolabeled monoclonal antibody 58 FOXO3a 58 bioactive lipid 58 DermaVir 58 ALN TTR 58 EBNA1 58 tyrosine kinase 58 STAT4 58 ToGA 58 cilengitide 58 zanolimumab 58 Mcl 1 58 Epothilones 58 Epstein Barr Virus EBV 58 LNCaP cells 58 ribonucleotide reductase clinically validated 58 potently inhibited 58 C#Y 58 EGFR TKI 58 T#I mutant 58 paragangliomas 58 telomerase reverse transcriptase 58 Cx# [001] 58 NeoLipid R 58 aromatase 58 YONDELIS 58 neuronal nitric oxide synthase 58 effector memory 58 58 gefitinib Iressa 58 neurite outgrowth 58 sPLA2 58 metalloproteinase 58 transient receptor 58 beta amyloid peptide 58 Triolex 58 mutational status 58 dacetuzumab 58 thyroid hormone receptor 58 KRAS status 58 DNMT1 58 olaparib 58 Factor VIIa 58 metastatic lesions 58 Sym# 58 transgenic mouse model 58 thrombospondin 58 radiolabeled 58 DNA methyltransferases 58 transcriptional activation 58 IFN alpha 58 IAP inhibitor 58 TrkB 58 VEGF receptors 58 serum antibody 58 interferon lambda 58 chemoresistant 58 epothilones 58 Hedgehog pathway 58 UsiRNAs 58 CD# expressing 58 fusion proteins 58 ALK inhibitor 58 BLyS 58 alkylating agents 58 kinase gene 58 copper zinc superoxide 58 MUC1 * 58 CEQ# 58 constitutively expressed 58 cytokine Interleukin 58 Kupffer cells 58 sequence homology 58 sortilin 58 Telintra 58 NOTCH1 58 NKT cell 58 genetic polymorphisms 58 Th2 cytokines 58 cysteine protease 58 IDH mutations 58 OncoVEX GM CSF 58 SOX9 58 interferon beta 58 immunomodulator 58 Tubulin 58 GRP# 58 hypereosinophilic syndrome 58 costimulatory molecules 58 evaluating tivozanib